The Director of the National Institutes of Health, Elias Zerhouni, M.D., has appointed Jill Buyon, MD and seven other new members to the NIH Peer Review Advisory Committee.
Dr. Buyon, is professor of medicine and associate director of the Division of Rheumatology, Department of Medicine, at the New York University School of Medicine. Dr. Buyon’s research interests include studies of tissue injury aspects of lupus disease and studies of the molecular aspects of congenital heart block in neonatal lupus. She will begin her term at the NIH in January, 2008.
The NIH Peer Review Advisory committee provides technical and scientific advice on matters related to the procedures and policies governing the scientific and technical evaluation of NIH grant applications. Peer review is the key method NIH uses to ensure that the $20+ billion it invests in biomedical research grants each year advances the most promising research.
"We're delighted to add such exceptional talent and experience," said Dr. Zerhouni. "Members of the NIH Peer Review Advisory Committee will play key roles as we accelerate efforts to enhance NIH peer review": http://enhancing-peer-review.nih.gov.
Established by law and charter, the Peer Review Advisory Committee meets 2-3 times a year and advises the NIH Director, the NIH Deputy Director for NIH Extramural Research and the Director of the NIH Center for Scientific Review (CSR). The committee is cochaired by Toni Scarpa, M.D., Ph.D., Director of CSR; and Jeremy Berg, Ph.D., Director of the National Institute of General Medical Sciences. The committee convened at NIH on August 27, 2007.